Cargando…
Emerging Treatment Options for Advanced or Recurrent Endometrial Cancer
Endometrial cancer is the most common cancer of the female reproductive organs. The American Cancer Society estimates that there will be over 65,950 new cases diagnosed in 2022. According to the National Comprehensive Cancer Network (NCCN) Guidelines, response rates in the front-line setting are app...
Autor principal: | Halla, Kimberly |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Harborside Press LLC
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805805/ https://www.ncbi.nlm.nih.gov/pubmed/35173988 http://dx.doi.org/10.6004/jadpro.2022.13.1.4 |
Ejemplares similares
-
Recurrent Endometrial Cancer: Local and Systemic Treatment Options
por: Rütten, Heidi, et al.
Publicado: (2021) -
Emerging treatment options for patients with recurrent advanced thymic epithelial tumors
por: Evans, Tracey L
Publicado: (2012) -
Advanced endometrial cancer: New medical treatment options on the horizon
por: Vistad, Ingvild, et al.
Publicado: (2023) -
Emerging treatment options for recurrent ovarian cancer: the potential role of olaparib
por: Shaw, Heather M, et al.
Publicado: (2013) -
New therapies for advanced, recurrent, and metastatic endometrial cancers
por: Makker, Vicky, et al.
Publicado: (2017)